Sinopharm Group Co. Ltd. (OTCMKTS:SHTDY – Get Free Report) was the target of a large decrease in short interest in August. As of August 14th, there was short interest totaling 15,265 shares, a decrease of 76.2% from the July 30th total of 64,023 shares. Based on an average daily volume of 128,100 shares, the short-interest ratio is presently 0.1 days.
Sinopharm Group Price Performance
Shares of SHTDY stock opened at $10.02 on Friday. The business’s 50-day moving average price is $10.71 and its 200-day moving average price is $11.84. Sinopharm Group has a 12 month low of $9.99 and a 12 month high of $14.87.
Sinopharm Group Company Profile
Sinopharm Group Co, Ltd. (OTCMKTS:SHTDY) is one of China’s largest integrated healthcare companies and an indirect subsidiary of the state-owned China National Pharmaceutical Group Co, Ltd. The company operates through two primary segments—pharmaceutical distribution and retail pharmacy—offering comprehensive supply chain solutions that span procurement, storage, transportation and sales of medical products. With a broad portfolio that includes prescription drugs, over-the counter medicines, medical devices and consumables, Sinopharm serves hospitals, clinics, retail pharmacies and other healthcare institutions across mainland China.
In its distribution business, Sinopharm leverages an extensive logistics network, comprising hundreds of distribution centers and thousands of delivery vehicles, to ensure timely delivery of pharmaceuticals under stringent temperature-controlled conditions.
See Also
- Five stocks we like better than Sinopharm Group
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Sinopharm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinopharm Group and related companies with MarketBeat.com's FREE daily email newsletter.
